ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 290 filers reported holding ALKERMES PLC in Q4 2015. The put-call ratio across all filers is 0.77 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,441 | -18.3% | 658,361 | -8.7% | 0.12% | -19.7% |
Q2 2023 | $22,572 | +2.2% | 721,138 | -8.0% | 0.15% | +2.0% |
Q1 2023 | $22,090 | -15.1% | 783,618 | -21.3% | 0.15% | -21.6% |
Q4 2022 | $26,013 | -99.9% | 995,507 | +22.4% | 0.19% | +43.9% |
Q3 2022 | $18,166,000 | -22.4% | 813,538 | +3.5% | 0.13% | -15.9% |
Q2 2022 | $23,407,000 | +90.9% | 785,741 | +68.6% | 0.16% | +149.2% |
Q1 2022 | $12,260,000 | +2289.9% | 465,974 | +2127.1% | 0.06% | +2000.0% |
Q2 2021 | $513,000 | +54.1% | 20,923 | +17.5% | 0.00% | +50.0% |
Q1 2021 | $333,000 | +14.8% | 17,806 | +22.3% | 0.00% | 0.0% |
Q4 2020 | $290,000 | -19.7% | 14,555 | -21.4% | 0.00% | -33.3% |
Q3 2019 | $361,000 | -51.2% | 18,509 | -43.6% | 0.00% | -50.0% |
Q2 2019 | $740,000 | -0.1% | 32,845 | +61.7% | 0.01% | 0.0% |
Q1 2019 | $741,000 | +12.8% | 20,314 | -8.8% | 0.01% | 0.0% |
Q4 2018 | $657,000 | -54.4% | 22,265 | -34.4% | 0.01% | -40.0% |
Q3 2018 | $1,440,000 | -16.4% | 33,931 | -18.9% | 0.01% | -9.1% |
Q2 2018 | $1,723,000 | -24.7% | 41,859 | +6.0% | 0.01% | -26.7% |
Q1 2018 | $2,288,000 | -2.6% | 39,472 | -8.0% | 0.02% | -6.2% |
Q4 2017 | $2,348,000 | +747.7% | 42,901 | +628.6% | 0.02% | +700.0% |
Q3 2016 | $277,000 | -40.2% | 5,888 | -45.0% | 0.00% | -33.3% |
Q2 2016 | $463,000 | +65.9% | 10,706 | +31.0% | 0.00% | +50.0% |
Q1 2016 | $279,000 | -3.5% | 8,172 | +124.7% | 0.00% | 0.0% |
Q4 2015 | $289,000 | -38.1% | 3,637 | -54.3% | 0.00% | -50.0% |
Q3 2015 | $467,000 | +27.6% | 7,965 | +39.9% | 0.00% | +33.3% |
Q2 2015 | $366,000 | +35.6% | 5,695 | +28.5% | 0.00% | +50.0% |
Q1 2015 | $270,000 | +4.2% | 4,432 | +0.3% | 0.00% | 0.0% |
Q4 2014 | $259,000 | +15.6% | 4,417 | -15.4% | 0.00% | 0.0% |
Q3 2014 | $224,000 | -15.2% | 5,223 | -0.6% | 0.00% | 0.0% |
Q2 2014 | $264,000 | +21.1% | 5,252 | +6.4% | 0.00% | 0.0% |
Q1 2014 | $218,000 | +11.2% | 4,936 | +2.6% | 0.00% | 0.0% |
Q4 2013 | $196,000 | – | 4,811 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 14,040,000 | $313,513,000 | 35.43% |
Krensavage Asset Management, LLC | 1,411,682 | $31,523,000 | 10.04% |
Prosight Management, LP | 502,150 | $11,213,000 | 6.01% |
Hardman Johnston Global Advisors LLC | 5,734,259 | $128,046,000 | 5.76% |
13D Management LLC | 415,055 | $9,268,000 | 4.85% |
Ally Bridge Group (NY) LLC | 300,000 | $6,699,000 | 4.42% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $13,248,000 | 4.25% |
GREAT POINT PARTNERS LLC | 507,500 | $11,332,000 | 2.73% |
Tamarack Advisers, LP | 200,000 | $4,466,000 | 2.62% |
Zebra Capital Management LLC | 22,134 | $494,000 | 1.88% |